US Corporate Board Director Changes SEC Filings — April 02, 2026

02-04-2026

Global Net Lease, Inc. (GNL) announced that board members Sue Perrotty and Governor Edward Rendell will retire effective immediately following the 2026 Annual Meeting of Stockholders and will not stand for re-election. They provided 11 and 14 years of service, respectively, including leadership through the 2023 merger and internalization. Post-meeting, the Board will consist of eight members if all nominees are elected.

• ·GNL is a publicly traded internally managed REIT (NYSE: GNL) focused on net lease assets in the U.S., Western and Northern Europe.
• ·Investor Relations contact: investorrelations@globalnetlease.com or (323) 265-2020.

02-04-2026

ESAB Corporation announced the appointment of R. Brent Jones as Chief Financial Officer effective early May 2026, succeeding Kevin Johnson who is departing to pursue a CFO role at a privately held company, with Johnson assisting in the transition. Jones brings over three decades of experience, including prior CFO roles at Avantor and Pall Corporation. Despite recent geopolitical events, ESAB reaffirms its previously announced 2026 guidance ranges for total core sales, aEBITDA, and aEPS.

• ·ESAB founded in 1904, based in North Bethesda, Maryland, serves customers in approximately 150 countries
• ·Kevin Johnson's tenure at ESAB: past seven years

02-04-2026

Flutter Entertainment plc announced that independent Director Alfred F. Hurley, Jr., who has served since June 2016, will retire after a ten-year term and not stand for re-election at the 2026 Annual General Meeting on May 29, 2026. John Bryant, Chair of the Board, thanked Hurley for his contributions, including during the U.S. listing transition and as Chair of the Compensation and Human Resources Committee. Effective post-AGM, Nancy Dubuc will replace Hurley as Chair of the Compensation and Human Resources Committee.

• ·Flutter notified the Board of Hurley's retirement decision.
• ·Enquiries: Edward Traynor, +353872232455

02-04-2026

Sally Beauty Holdings, Inc. (NYSE: SBH) appointed Adrianne Lee as Senior Vice President and Chief Financial Officer effective April 28, 2026, succeeding Marlo Cormier, who will depart effective April 11, 2026, to pursue other opportunities. Ms. Lee brings extensive finance leadership experience from Bed Bath & Beyond, The Hertz Corporation, and other firms. The Company reaffirmed its previously issued second quarter and fiscal year 2026 financial guidance.

• ·Adrianne Lee previously served as President and CFO at Bed Bath & Beyond, joining as CFO in 2020
• ·Guidance for Q2 and FY2026 originally provided on February 9, 2026
• ·Sally Beauty operates through Sally Beauty and Beauty Systems Group segments

02-04-2026

On March 31, 2026, Leiden Dworak notified TScan Therapeutics, Inc. of his resignation as Vice President of Finance and principal accounting officer, effective April 10, 2026, with no disagreements on operations, policies, or practices. The Board of Directors appointed Jason A. Amello, the current Chief Financial Officer and principal financial officer, as the new principal accounting officer effective the same date. Mr. Amello will receive no additional compensation for the role, and no changes were made to his existing plans or arrangements.

• ·Resignation notification date: March 31, 2026
• ·Effective date of resignation and appointment: April 10, 2026
• ·Mr. Amello's background incorporated by reference from definitive proxy statement on Schedule 14A filed May 14, 2025

02-04-2026

Oportun Financial Corporation announced that Kate Layton (Chief Legal Officer and Corporate Secretary) and Gaurav Rana (General Manager of Lending) will jointly lead as interim CEOs effective April 4, 2026, following the previously announced departure of Raul Vazquez as CEO and Board member. Vazquez will serve as an advisor until July 3, 2026, while the Board advances its search for a permanent CEO. Lead Independent Director Louis P. Miramontes highlighted progress in the CEO selection process and praised the interim leaders' deep business knowledge.

• ·Kate Layton joined Oportun in 2015, previously Deputy General Counsel and Corporate Secretary.
• ·Gaurav Rana joined Oportun in 2017 as Head of Data and Analytics.
• ·Investor Contact: Dorian Hare (650) 590-4323, ir@oportun.com

02-04-2026

Tripadvisor, Inc. announced the departure of Seth Kalvert as Chief Legal Officer and Secretary, effective May 1, 2026, treated as a Qualifying Termination under the Amended and Restated Executive Severance Plan. The departure is not due to any disagreements with the Company on operations, policies, or practices. Mr. Kalvert will remain available in an advisory capacity for transition services, with terms to be mutually agreed.

02-04-2026

Coya Therapeutics announced that founder Howard Berman, Ph.D., stepped down as Executive Chairman and Director following the November 2024 CEO transition to Arun Swaminathan, Ph.D. Mark H. Pavao, with over 30 years of biopharma commercial experience, was appointed as an independent director to fill the vacancy. The company continues advancing its lead asset COYA 302 in the Phase 2B ALSTARS trial for ALS.

• ·ALSTARS Trial: Phase 2, randomized, multi-center, double-blind, placebo-controlled study (NCT07161999)
• ·Headquartered in Houston, TX
• ·CEO transition initiated November 2024

02-04-2026

On March 27, 2026, Jones Soda Co. amended the terms of a stock option grant to its Chief Financial Officer, Brian Meadows, originally issued on September 9, 2025, for 750,000 shares of common stock under the 2022 Omnibus Equity Incentive Plan. The amendment removes prior performance milestones and establishes vesting over three years with one-third cliff vesting on each anniversary starting March 27, 2026, subject to continued employment. No other changes to officer positions or departures were reported.

• ·Amendment filed under Item 5.02 of Form 8-K
• ·Report signed by Scott Harvey on April 2, 2026

02-04-2026

On March 30, 2026, Aparna Bawa notified Zoom Communications, Inc. of her resignation as Chief Operating Officer, effective May 8, 2026. The departure is not due to any disagreement with the company. The 8-K filing was submitted on April 2, 2026, and signed by Michelle Chang, Chief Financial Officer.

• ·Company address: 55 Almaden Boulevard, 6th Floor, San Jose, California 95113
• ·Class A Common Stock ($0.001 par value) traded on Nasdaq Global Select Market under symbol ZM

02-04-2026

On March 27, 2026, Cingulate Inc. appointed Zhanpeng “Frederick” Jiang as a Class I director, effective immediately following stockholder approval of the Issuance Proposal, to serve until the 2028 Annual Meeting. Mr. Jiang, determined to be independent, was also appointed to the Audit, Compensation, and Nominating and Corporate Governance Committees. He was granted an option to purchase 15,000 shares of common stock and annual cash retainers of $40,000 for Board service plus $7,500, $5,000, and $4,000 for committee services.

• ·Mr. Jiang's stock option has an exercise price equal to the last reported sale price on Nasdaq on grant date and vests in two equal installments over one year.
• ·Filing references prior Form 8-K dated January 28, 2026, for securities purchase agreement details.
• ·Company is an emerging growth company under Rule 405/12b-2.

02-04-2026

Mama’s Creations, Inc. (NASDAQ: MAMA) appointed Fred Halvin, a veteran corporate development executive with 37 years at Hormel Foods, to its Board of Directors on April 2, 2026. Halvin directed over 20 M&A transactions totaling $8 billion, including acquisitions like Planters, Columbus, Applegate, Skippy, and Muscle Milk. Chairman and CEO Adam L. Michaels praised Halvin’s expertise in acquisitions, joint ventures, and strategic growth as aligned with the company’s vision to become a premier deli solutions provider.

• ·Mama’s Creations products found in over 12,000 grocery, mass, club and convenience stores nationally.
• ·Fred Halvin previously held roles at Hormel Foods as Director of Investor Relations & EVA Analysis, Treasurer, Assistant Controller, and Corporate Tax Manager.
• ·Fred Halvin holds a B.A. in Accounting from Midland University and completed the Management Executive Program at the Carlson School of Management.

02-04-2026

Riverview Bancorp, Inc. (NASDAQ: RVSB) appointed Kourosh Zamani and Jon Girod to its Board of Directors for Riverview Bank and Riverview Bancorp, effective immediately on April 2, 2026. Zamani, co-founder of AI technology firm Laurel (raised over $150M), and Girod, owner of Quail Homes who built over 3,000 homes and developed more than 2,000 lots, bring expertise in technology, business development, and community real estate. The company reports $1.51B in assets as of December 31, 2025, with 17 branches focused on community banking.

• ·Riverview Bank is 103 years old.
• ·Named Best Bank by readers of The Columbian for the past 12 years.
• ·Headquartered in Vancouver, WA, with focus on commercial, business, and retail clients.

02-04-2026

On April 1, 2026, the Board of Directors of Tyra Biosciences, Inc. designated Julia Rueb, Vice President, Finance, as the company's principal accounting officer, succeeding Alan Fuhrman in that role. Mr. Fuhrman continues to serve as the principal financial officer and Chief Financial Officer. This is a routine internal designation with no reported changes to executive leadership structure.

• ·Ms. Rueb, 40, has served as VP Finance since January 2024, previously Director/Senior Director of Accounting and Corporate Controller (Oct 2022-Dec 2023).
• ·Ms. Rueb holds a Master’s degree in Accounting from the University of San Diego and is a Certified Public Accountant.
• ·Ms. Rueb has no family relationships with any of the company’s directors or executive officers.
• ·Common Stock (TYRA) trades on Nasdaq Global Select Market; company is an emerging growth company.

02-04-2026

TFS Financial Corporation's primary subsidiary, Third Federal Savings & Loan Association of Cleveland, announced the retirement of Meredith S. Weil as Board of Directors member and Chief Financial Officer effective January 2027, following nearly 30 years with the company including roles as COO and Board member since 2014. James E. LaRocca, formerly EVP and CFO of Westfield Bank (acquired by First Financial Bancorp in November 2025), will join as Finance and Accounting Officer on June 29, 2026, and is expected to assume the CFO role. As of December 31, 2025, the company's assets totaled $17.50 billion.

• ·Third Federal founded in 1938 as a mutual association and became part of public company in 2007 (Nasdaq: TFSL)
• ·Ms. Weil served as COO from 2012-2023 and CFO since 2024
• ·Mr. LaRocca held BA in Accounting and MBA from Baldwin-Wallace University; licensed CPA in Ohio

02-04-2026

Nexscient, Inc. appointed Eric Sherb as Chief Financial Officer effective April 1, 2026, via a consulting agreement with EMS Consulting Services, Inc., which includes a $5,000 monthly retainer and a one-time grant of 36,000 common shares vesting over six months. Mr. Sherb, a CPA with 19 years of experience from firms like PricewaterhouseCoopers and prior CFO roles at public companies including Scienture Holdings, Inc., was engaged to provide CFO-level financial and accounting services. The agreement is terminable by either party at any time, with no family relationships or other disclosable transactions involving Mr. Sherb.

• ·Consulting agreement dated March 31, 2026.
• ·Mr. Sherb's experience includes IPOs, SPACs, de-SPACs, debt/equity financings.
• ·No family relationships with directors or officers.
• ·No transactions requiring disclosure under Item 404(a) of Regulation S-K.

02-04-2026

TaskUs, Inc. received notice from Jacqueline D. Reses of her resignation as a Class I director, effective immediately following the 2026 Annual Meeting of Stockholders expected on or around May 21, 2026, prompting a board size reduction from nine to eight members. BCP FC Aggregator LP requested the substitution of Amit Dalmia for Amit Dixit as a Blackstone Designee and Class II director at the 2026 AGM, with Mr. Dalmia's term extending until the 2029 AGM. Neither the resignation nor substitution stems from any disagreements with the company, management, or board.

• ·Date of earliest event: March 27, 2026
• ·Proxy Statement to be filed with SEC on or around April 10, 2026
• ·Substitution pursuant to Amended and Restated Stockholders Agreement dated June 15, 2021

02-04-2026

On March 27, 2026, the Board of Directors of MAIA Biotechnology, Inc. approved one-time bonus payments totaling $362,610, including $312,610 to CEO Vlad Vitoc and $50,000 to Head of Finance Jeffrey Himmelreich, in recognition of their efforts in a recent capital raise. The payments were made on March 31, 2026. No other material changes in officers or directors were reported.

• ·Bonus payments approved under Item 5.02 for compensatory arrangements related to recent capital raise.
• ·Filing signed by Vlad Vitoc on April 2, 2026.

02-04-2026

Motorsport Games Inc. entered into employment agreements on March 27, 2026, appointing Stephen Hood as Chief Executive Officer with an annual base salary of £378,000 and eligibility for a 50% target bonus, and Stanley Beckley as Chief Financial Officer with a $300,000 base salary and 25% target bonus. Both executives are eligible for equity awards under the 2021 Equity Incentive Plan and subject to restrictive covenants. No prior executive departures are mentioned in the filing.

• ·Hood Employment Agreement: 6-month notice by employee, 18-month by company; payment in lieu option; non-compete for 12 months post-employment.
• ·Beckley Employment Agreement: 6-month severance without cause; full equity vesting acceleration on change in control termination within 12 months; non-compete for 18 months post-employment.

02-04-2026

Cable One, Inc. announced on March 27, 2026, that Kenneth E. Johnson will step down as Chief Operating Officer effective May 1, 2026, transitioning to a senior advisor role until January 2027. The departure is not due to any disagreement regarding the company's operations, policies, practices, controls, or financial/accounting matters. No successor has been named in the filing.

• ·Company headquartered at 210 E. Earll Drive, Phoenix, Arizona 85012
• ·Common Stock (CABO) traded on New York Stock Exchange

02-04-2026

Minerva Neurosciences, Inc. (NERV) announced a leadership transition with the appointment of Jim O’Connor as Chief Business Officer and General Counsel effective April 21, 2026, as Geoff Race steps down from his role as President after 16 years but will continue as a consultant. Dr. Remy Luthringer expressed gratitude for Race's foundational contributions and confidence in O’Connor to advance roluperidone through its next Phase 3 trial. O’Connor brings over 20 years of experience, including negotiating >$130 million in financings and FDA regulatory successes.

• ·Jim O’Connor previously served at Axena Health in roles including General Counsel & Chief Operating Officer, General Counsel & Chief Financial Officer, and Interim CEO.
• ·O’Connor oversaw FDA 510(k) clearance, label expansions, and FDA Breakthrough Device Designation via appeal.
• ·Geoff Race joined Minerva in 2010 and held roles including EVP & CFO and Chief Business Officer.
• ·Filing date: April 02, 2026

02-04-2026

Bank of Marin Bancorp (Nasdaq: BMRC) announced a webcast of its Q1 2026 earnings call on April 27, 2026, at 8:30 a.m. PT, where President and CEO Tim Myers and EVP and CFO Dave Bonaccorso will discuss results for the fiscal first quarter ended March 31, 2026. The company, with $3.9 billion in assets, operates 27 branches and eight commercial banking offices in Northern California. A replay will be available on the company's investor relations website.

• ·Founded in 1990 and headquartered in Novato, CA.
• ·Consistently ranked one of the “Top Corporate Philanthropists" by San Francisco Business Times since 2003.
• ·Ranked top 13 in Sacramento Business Journal’s 2025 Corporate Direct Giving List.
• ·Recognized as one of North Bay Business Journal’s “Best Places to Work” in 2025.
• ·Inducted into North Bay Biz’s “Best of” Hall of Fame in 2024.
• ·Included in the Russell 2000 Small-Cap Index and Nasdaq ABA Community Bank Index.

02-04-2026

Booking Holdings Inc. announced the appointment of Caroline Sullivan as Senior Vice President, Chief Accounting Officer, and Controller, effective April 29, 2026. Ms. Sullivan, aged 57, has prior experience as Vice President at Elevance Health (June 2025–March 2026), Senior Vice President, Chief Accounting Officer and Corporate Controller at Moody's Corporation (2018–2025), and roles at Bank of America, Morgan Stanley, Allied Irish Bank, and Ernst & Young. Compensation package includes an initial base salary of $525,000, target annual bonus of 75% of base salary, equity grants with $3,000,000 total grant date fair value, and a $300,000 signing bonus.

• ·RSUs and new hire RSUs vest in three equal annual installments, with pro rata vesting on termination without cause or disability, and full vesting on death.
• ·PSU award vests based on service and performance provisions consistent with 2027 executive grants under the 1999 Omnibus Plan.
• ·Entered into Non-Competition and Non-Solicitation Agreement and Employee Confidentiality and Assignment Agreement.
• ·Severance on termination without cause includes 1x base salary and target bonus, pro-rated bonus if after June 30, 12 months health benefits, and prior earned bonus.

02-04-2026

Peoples Financial Services Corp. appointed Gerard A. Champi as President of Peoples and Peoples Security Bank and Trust Company effective April 3, 2026, succeeding Thomas P. Tulaney who is retiring on the same date; Champi will continue as CEO. Tulaney entered a consulting agreement with Peoples Bank for senior advisory services at $8,000 per month. Director Elisa Zúñiga Ramirez provided notice on April 1, 2026, that she will not stand for reelection at the 2026 annual meeting, with no disagreements cited, leading to board size reductions.

• ·No family relationship between Gerard A. Champi and any other director or executive officer.
• ·Gerard A. Champi not involved in any Item 404(a) disclosable transactions.
• ·Elisa Zúñiga Ramirez's decision to not stand for reelection not due to any disagreement with Peoples.
• ·Consulting agreement terminable by either party with 30 days' written notice.
• ·Peoples accelerated vesting of Tulaney's awards and transferred company-owned vehicle upon retirement.

02-04-2026

Charles River Associates (CRAI) announced that Director Christine Detrick will assume the role of Lead Independent Director effective July 16, 2026, following the retirement of current Lead Independent Director William Concannon after 26 years of service. Concannon, who has been on the board since 2000 and Lead Director since 2020, plans to retire to spend more time with family. The appointment is subject to Detrick's re-election at the 2026 Annual Meeting of Shareholders.

• ·CRA’s 2026 Annual Meeting of Shareholders scheduled for July 16, 2026.
• ·Christine Detrick has served on the board since 2020 and is Chairperson of the Nominating and Corporate Governance Committee.
• ·William Concannon informed the board of his retirement decision to spend more time with family and other activities.

02-04-2026

On March 31, 2026, the Board of Directors of Jade Biosciences, Inc. approved the 2026 Employment Inducement Stock Incentive Plan, reserving 1,750,000 shares of common stock for issuance. The plan mirrors the 2025 Stock Incentive Plan but restricts awards to new employees per Nasdaq Rule 5635(c)(4), without stockholder approval or incentive stock options. The Company plans to include full plan details in its Form 10-Q for the quarter ended March 31, 2026.

• ·Awards under the plan may only be granted to employees not previously employed by the Company or following a bona fide non-employment period, as an inducement to commence employment.
• ·The Company will file the complete 2026 Inducement Plan and related stock option and restricted stock unit agreements as exhibits to its Q1 2026 Form 10-Q.

02-04-2026

The Compensation Committee approved FY2025 non-equity incentive plan payments for named executive officers, resulting in total compensation increases versus FY2024, with CEO Charles E. Bradley, Jr. at $5,439,647 (up 31%, though salary flat at $995,000), President Michael T. Lavin at $1,386,590 (up 44%, salary flat at $470,000), and CFO Danny Bharwani at $1,254,849 (up 43%, salary up 12% to $430,762). These updates revise the Summary Compensation Table from the March 16, 2026 10-K filing. CEO bonus of $3,283,500 reflects performance against objectives including quarterly budgets, four securitizations, originations targets up to $2.1 billion, expense reductions, and stock price milestones.

• ·Option awards valued using Black-Scholes model: weighted average fair value $3.80 per option (4.11 years expected life, 53.94% volatility, 4.10% risk-free rate).
• ·CEO bonus objectives weighted up to 720% of base salary, including 80% for budgets/securitizations/originations/stock targets, 200% for 1% expense cut, 100% for financing deals.

02-04-2026

Tyson Foods, Inc. announced on April 2, 2026, the appointment of Phillip Thomas as Vice President, Controller and Chief Accounting Officer effective April 6, 2026, succeeding Lori Bondar who will step down from the Chief Accounting Officer role but remain as Senior Vice President to assist with the transition before retiring by fiscal year-end. Mr. Thomas, an internal candidate previously serving as Vice President and Controller since December 2023, has a long tenure with the company including prior stints in similar roles. His compensation includes an annual base salary of $360,574, target annual incentive of 55% of base salary, and long-term incentive target of $175,000.

• ·Phillip Thomas, age 51, previously served as Vice President and Controller (Dec 2023-present), Vice President, Controller and Chief Accounting Officer (Jul 2020-Dec 2023), Vice President and Assistant Controller (Mar 2014-Jul 2020), and Senior Director Financial Reporting (Jul 2008-Mar 2014).
• ·Long-term incentive award mix: 75% restricted stock units, 25% performance stock.
• ·No family relationship between Mr. Thomas and any director or officer; no arrangement or understanding pursuant to his selection; not party to any related party transactions under Item 404(a) of Regulation S-K.

02-04-2026

PharmaCyte Biotech, Inc. (PMCB) held its annual stockholder meeting on March 30, 2026, with a quorum of 7,387,861 shares representing 55.08% of outstanding voting stock. Stockholders approved the election of five directors (Joshua N. Silverman, Jonathan L. Schechter, Michael M. Abecassis, Robert Weinstein, and Wayne R. Walker), ratification of CBIZ CPAs P.C. as auditors, advisory approval of executive compensation, authorization for a potential reverse stock split (1-for-1.1 to 1-for-100), and an amendment to the 2022 Equity Incentive Plan increasing available shares by 2,000,000; all proposals passed with majority support despite some opposition (e.g., 2,280,497 against reverse split) and withheld votes/broker non-votes on directors.

• ·Proposal 2 (auditor ratification): 6,837,442 For, 514,469 Against, 35,950 Abstain
• ·Proposal 3 (exec comp): 3,306,883 For, 625,080 Against, 15,322 Abstain
• ·Proposal 4 (reverse split): 5,067,304 For, 2,280,497 Against, 40,056 Abstain
• ·Proposal 5 (plan amendment): 3,133,280 For, 804,435 Against, 9,572 Abstain
• ·Director votes: Joshua N. Silverman (3,563,982 For, 383,306 Withheld); others similarly with 3.4M-3.6M For and 372k-550k Withheld

02-04-2026

Dan Whalen resigned from Harmonic Inc.'s Board of Directors effective March 31, 2026, due to potential conflicts of interest arising from his acceptance of a new role at another company. The resignation was not the result of any disagreement with Harmonic's operations, policies, or practices. Mr. Whalen had served on the Board since 2024, following prior service from 2021 to 2023, and was a member of the Audit Committee and Compensation Committee.

• ·Filing submitted on April 2, 2026, reporting the event of March 31, 2026

02-04-2026

Mativ Holdings, Inc. announced on March 30, 2026, that Ryan Elwart, its Group President, tendered his resignation effective April 27, 2026, to pursue other opportunities. The 8-K filing was made on April 2, 2026, under Items 5.02 and 9.01. No information on a successor or any financial impact was provided.

• ·Commission file number: 1-13948
• ·I.R.S. Employer Identification No.: 62-1612879
• ·Common Stock traded as MATV on New York Stock Exchange

02-04-2026

Vanda Pharmaceuticals Inc. announced that Timothy Williams resigned as Senior Vice President, General Counsel and Secretary, effective April 10, 2026, after notifying the company on March 29, 2026, to pursue other endeavors. The Form 8-K was filed on April 2, 2026, and signed by Kevin Moran, Senior Vice President, Chief Financial Officer and Treasurer. No successor has been named in the filing.

02-04-2026

Kiora Pharmaceuticals announced the departure of Eric J. Daniels, M.D., MBA, as Chief Development Officer on April 17, 2026, to pursue other opportunities, with the company initiating a search for a successor; President and CEO Brian M. Strem thanked him for his contributions. Despite the leadership change, Kiora remains focused on its retinal disease pipeline, with the ABACUS-2 Phase 2 trial (KIO-301) approved to enroll remaining patients in the 50µg dose cohort and initiate the 100µg dose cohort following a safety review, and the KLARITY Phase 2 trial (KIO-104) having cleared all safety checkpoints with ongoing enrollment.

• ·KIO-301 initially for retinitis pigmentosa, with potential expansion to choroideremia and Stargardt disease; molecular photoswitch to restore vision.
• ·KIO-104 for macular edema due to retinal inflammation; next-generation non-steroidal DHODH inhibitor.
• ·Annual Report on Form 10-K filed March 25, 2026; Form 10-Q filed November 7, 2025.

02-04-2026

On April 1, 2026, Dr. Peter Slavin notified American Well Corporation that he will resign from the Board of Directors, effective at the Company's next annual meeting of stockholders in 2026, due to his transition to a new role on the West Coast. Dr. Slavin will continue serving as a director until that meeting, and his resignation is not due to any disagreement with the Company's operations, policies, or procedures. The Company acknowledged his more than nine years of service on the Board.

02-04-2026

Sysco Corporation announced that Tom Peck, Executive Vice President and Chief Information and Digital Officer, notified the company of his resignation effective April 10, 2026, to pursue an opportunity in a different industry. There were no disagreements between Mr. Peck and the company regarding operations, policies, or practices. The resignation does not indicate any operational issues.

• ·Notification received on March 27, 2026
• ·8-K filed on April 2, 2026

02-04-2026

Calidi Biotherapeutics, Inc. disclosed that Director Allan J. Camaisa intends to allow his Board term to expire at the 2026 annual stockholder meeting, with no disagreements on company operations, policies, or practices. The Board will reduce its size from six to five directors effective that date by eliminating a Class III vacancy. Separately, Scott Leftwich, a Class III director, was appointed to the Audit Committee effective April 1, 2026.

• ·Camaisa's notice provided on March 29, 2026
• ·Board actions on reduction and appointment taken on April 1, 2026

02-04-2026

InTest Corporation (NYSE American: INTT) promoted Rich Rogoff, Division President of Environmental Technologies, to President, Chief Executive Officer, and Board member effective immediately, replacing Nick Grant who served in those roles since 2020. Rogoff, who joined in October 2021, led acquisitions of Acculogic, Videology, and Alfamation, and helped establish the Center of Excellence in Penang, Malaysia. Chairman Joe Dews noted the Board's confidence in Rogoff's ability to drive growth and profitability via the Operating Efficiency Committee.

• ·Rich Rogoff joined InTest in October 2021 as Vice President Corporate Development; promoted to Division President Environmental Technologies in June 2025.
• ·Operating Efficiency Committee established in April 2025.
• ·Contacts: Duncan Gilmour (856-505-8999), Alliance Advisors IR (212-838-3777)

02-04-2026

Optimum Communications, Inc. (OPTU) announced that Michael E. Olsen, Executive Vice President, General Counsel and Chief Corporate Responsibility Officer, will transition from his current role effective October 1, 2026 (or earlier upon successor appointment) to Senior Executive Counsel, Capital Transformation through December 31, 2027, after which he will retire. Under the Transition, Retention and Retirement Agreement dated April 1, 2026, Mr. Olsen will receive a $3,575,000 lump-sum cash retention payment, fully earned on December 31, 2027, subject to continued employment, with no repayment required in qualifying terminations (e.g., without cause, good reason, death, or disability). Through the Transition Date, he continues current base salary and incentive eligibility; post-transition, base salary, benefits, and vesting continue but no new incentives.

• ·In qualifying termination prior to December 31, 2027, entitled to lump sum base salary through that date and continued vesting of long-term incentive awards, subject to separation agreement and covenants.
• ·Transition Agreement provides continued indemnification, D&O insurance coverage, and customary confidentiality, non-disparagement, and restrictive covenants.
• ·Full Transition Agreement to be filed with Quarterly Report on Form 10-Q.

02-04-2026

On March 31, 2026, Regenerex Pharma, Inc. placed its Chief Financial Officer, Kenneth Perry, on paid administrative suspension leave effective immediately due to concerns including compliance with Board directives, financial oversight, corporate governance, financial reporting processes, and internal controls, with duties reassigned to an interim CFO. Effective April 1, 2026, the Board appointed Don E. Ray as Interim CFO for an initial 90-day term at an annual salary of $150,000. The review of these matters is ongoing with no final determinations made.

• ·Mr. Ray's background includes prior roles as Co-Managing Partner at Dixon Hughes Goodman/Forvis Mazars, Interim CFO at Price Simms Family Dealerships (2013-2019), and CFO at Diamond Automotive Group.
• ·Mr. Perry remains an employee during suspension and continues to receive base salary and benefits.

02-04-2026

RYVYL Inc. shareholders approved the merger with Roundtable (RTB Digital Inc.) at a Special Meeting on April 1, 2026, with 99% of votes cast in favor, clearing the final corporate hurdle. The combined company is expected to list on Nasdaq as RTB Digital Inc. under ticker RTB, subject to Nasdaq approval of the initial listing application. Roundtable's platform targets the $200B global media industry with Web3 and AI technologies.

• ·Special Meeting of Shareholders held on April 1, 2026
• ·Merger anticipated to consummate imminently, subject to Nasdaq approval
• ·Roundtable website: RTB.io
• ·RYVYL IR Contact: 973-873-7686, ryvylinvestor@allianceadvisors.com
• ·Roundtable PR Contact: +91 90289 77198, press@roundtable.io

02-04-2026

Xerox Holdings Corporation announced that Steve Bandrowczak will step down as Chief Executive Officer, with Louie Pastor appointed as the new CEO effective immediately. The Board, led by Chairman Scott Letier, thanked Bandrowczak for his leadership including successful acquisitions of Lexmark and ITsavvy, and expressed confidence in Pastor's operational expertise to drive strategy and execution. The company reaffirmed its full-year 2026 financial guidance and remains on track for its targets.

• ·Xerox acquired Lexmark in 2025 to expand global footprint and service capabilities.
• ·Louie Pastor previously served as President and Chief Operating Officer, leading enterprise transformation, global service delivery, revenue operations, marketing, communications, and people/technology organizations.
• ·Announcement dated March 30, 2026; SEC filing dated April 02, 2026.

02-04-2026

Broadcom Inc. announced that CFO Kirsten M. Spears will retire effective June 12, 2026, and the Board appointed Amie Thuener, previously Vice President, Corporate Controller and Chief Accounting Officer at Alphabet Inc., as successor CFO effective the same date, with her employment starting May 4, 2026. Ms. Spears will provide consulting services until March 15, 2027, with her equity awards continuing to vest. Ms. Thuener's compensation includes a $700,000 annual base salary, $1,000,000 sign-on bonus, 50,000 RSUs, and 50,000 PSUs at target.

• ·Amie Thuener's employment commences May 4, 2026; equity awards expected June 15, 2026.
• ·PSUs vest based on Broadcom's total stockholder return vs. S&P 500 and absolute TSR over four performance periods ending March 1, 2027-2030, with max vesting at 200% of target.
• ·No family relationships or material interests for Ms. Thuener per Reg S-K Items 401(d) and 404(a).

02-04-2026

Westlake Corporation's Board approved the transition of Robert F. Buesinger, Executive Vice President and Performance & Essential Materials Segment Head, to Special Advisor to the President effective April 2, 2026, ahead of his retirement. Brian Powers was appointed as the new Senior Vice President and Performance & Essential Materials Segment Head, effective the same date. The changes were announced following a Board decision on March 30, 2026.

02-04-2026

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) appointed Peter Anastasiou as Chief Operating Officer, effective with his resignation from the Board of Directors. The company also appointed Troy Ignelzi as a director to fill the vacancy and nominated Geno J. Germano for election at the 2026 Annual Meeting of Shareholders, while Antonio Gracias will not stand for re-election. These changes are positioned to support the company's next phase of growth and long-term value creation.

• ·Announcement date: April 2, 2026
• ·Harmony headquartered in Plymouth Meeting, Pa.
• ·2026 Annual Meeting of Shareholders for director elections

02-04-2026

Selig Zises resigned from all director and committee positions at Esquire Financial Holdings, Inc., Esquire Bank, National Association, and their affiliates, effective immediately on March 31, 2026, after over 17 years of service. The resignation is due to personal health and related disability concerns. It is explicitly stated that the resignation does not result from any disagreement with the Company or the Bank.

• ·Filing submitted on April 02, 2026 under Items 5.02 and 9.01

02-04-2026

Illumina, Inc. (NASDAQ: ILMN) announced changes to its Board of Directors ahead of the upcoming annual shareholder meeting: Frances Arnold, PhD, Robert S. Epstein, MD, and Gary S. Guthart, PhD, will retire, while David P. King has been nominated for election. Scott Gottlieb, MD, Board Chair, thanked the departing directors for their service during a period of transformation and praised King's extensive healthcare and life sciences experience, including as former CEO of LabCorp. The changes aim to support Illumina's next phase of growth and innovation in genomics.

• ·David P. King served as a partner at Hogan & Hartson LLP prior to joining LabCorp in 2001, leading its healthcare fraud and abuse practice.
• ·King's recent board roles include ZimVie (2022-2025) and VaxCare (2021-2025).
• ·Illumina's products serve research, clinical, applied markets including life sciences, oncology, reproductive health, and agriculture.

02-04-2026

Landstar System, Inc. announced on April 2, 2026, that Michael K. Kneller, Vice President, General Counsel and Secretary and an Executive Officer since 2005, will resign effective May 8, 2026, to join the law firm Scopelitis, Garvin, Light, Hanson & Feary, P.C. Vallie S. Dugas, currently Vice President and Assistant General Counsel, has been appointed as Interim Vice President, General Counsel and Secretary effective the same date.

• ·Michael K. Kneller has served as an Executive Officer since 2005

02-04-2026

TopBuild Corp. (NYSE: BLD) promoted John Achille, previously Chief Operating Officer, to President and Chief Operating Officer effective April 2, 2026, with responsibilities for Installation Services, Specialty Distribution, Supply Chain, and growth initiatives including M&A, reporting to CEO Robert Buck. The promotion highlights Achille's track record in delivering results across multiple businesses. Management expressed optimism about the company's flexible model, diversification, strong free cash flow, and commitment to shareholder returns.

• ·John Achille joined TopBuild in 2021 via acquisition of American Building Systems.
• ·Previously served as Executive Vice President of TruTeam and held roles at Distribution International and Service Partners.
• ·Headquartered in Daytona Beach, Florida.

02-04-2026

Campbell Fund Trust sold Units of Beneficial Interest on March 31, 2026, for aggregate consideration of $980,000.00 (Series A), $805,294.11 (Series D), and $275,000.00 (Series W) in private transactions exempt under Section 4(2) and Regulation D of the Securities Act. Effective March 30, 2026, Philippe Pradel was promoted to Chief Compliance Officer and Deputy General Counsel of Campbell & Company, LP, as part of succession planning, with Thomas Lloyd continuing as General Counsel.

• ·Transactions not registered under the Securities Act as they were private offerings pursuant to Regulation D
• ·Thomas Lloyd has served as General Counsel for over 20 years and CCO for most of that period

02-04-2026

AAON, Inc. announces the appointment of Andy Cheung as Executive Vice President and Chief Financial Officer effective April 20, 2026, succeeding Rebecca Thompson, who will transition to Chief Accounting Officer. Luke Bomer has joined as General Counsel effective April 1, 2026, in a newly created role to enhance governance and compliance. These leadership changes are positioned to support the company's growth, financial discipline, and long-term value creation.

• ·Andy Cheung previously served as EVP and CFO at Commercial Vehicle Group Inc. for three years and has over 25 years in HVAC and automotive finance.
• ·Rebecca Thompson held Chief Accounting Officer role prior to becoming CFO in 2021.
• ·Luke Bomer served as outside counsel and corporate secretary to AAON since 2015 at Johnson & Jones.
• ·AAON founded in 1988 and headquartered in Tulsa, Oklahoma.